TY - JOUR
T1 - Antiviral fibrils of self-assembled peptides with tunable compositions
AU - Dodd-o, Joseph
AU - Roy, Abhishek
AU - Siddiqui, Zain
AU - Jafari, Roya
AU - Coppola, Francesco
AU - Ramasamy, Santhamani
AU - Kolloli, Afsal
AU - Kumar, Dilip
AU - Kaundal, Soni
AU - Zhao, Boyan
AU - Kumar, Ranjeet
AU - Robang, Alicia S.
AU - Li, Jeffrey
AU - Azizogli, Abdul Rahman
AU - Pai, Varun
AU - Acevedo-Jake, Amanda
AU - Heffernan, Corey
AU - Lucas, Alexandra
AU - McShan, Andrew C.
AU - Paravastu, Anant K.
AU - Prasad, B. V.Venkataram
AU - Subbian, Selvakumar
AU - Král, Petr
AU - Kumar, Vivek
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - The lasting threat of viral pandemics necessitates the development of tailorable first-response antivirals with specific but adaptive architectures for treatment of novel viral infections. Here, such an antiviral platform has been developed based on a mixture of hetero-peptides self-assembled into functionalized β-sheets capable of specific multivalent binding to viral protein complexes. One domain of each hetero-peptide is designed to specifically bind to certain viral proteins, while another domain self-assembles into fibrils with epitope binding characteristics determined by the types of peptides and their molar fractions. The self-assembled fibrils maintain enhanced binding to viral protein complexes and retain high resilience to viral mutations. This method is experimentally and computationally tested using short peptides that specifically bind to Spike proteins of SARS-CoV-2. This platform is efficacious, inexpensive, and stable with excellent tolerability.
AB - The lasting threat of viral pandemics necessitates the development of tailorable first-response antivirals with specific but adaptive architectures for treatment of novel viral infections. Here, such an antiviral platform has been developed based on a mixture of hetero-peptides self-assembled into functionalized β-sheets capable of specific multivalent binding to viral protein complexes. One domain of each hetero-peptide is designed to specifically bind to certain viral proteins, while another domain self-assembles into fibrils with epitope binding characteristics determined by the types of peptides and their molar fractions. The self-assembled fibrils maintain enhanced binding to viral protein complexes and retain high resilience to viral mutations. This method is experimentally and computationally tested using short peptides that specifically bind to Spike proteins of SARS-CoV-2. This platform is efficacious, inexpensive, and stable with excellent tolerability.
UR - http://www.scopus.com/inward/record.url?scp=85184698292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85184698292&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-45193-3
DO - 10.1038/s41467-024-45193-3
M3 - Article
C2 - 38326301
AN - SCOPUS:85184698292
SN - 2041-1723
VL - 15
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 1142
ER -